The ethics of disease-modifying drugs targeting Alzheimer disease
Response to our commentators
Bibliographic Data
| ID | 21514723 |
|---|---|
| Authors | Erik Gustavsson (0000-0001-5448-9209, Linköping University, corresponding author), Pauline Raaschou (Karolinska Institutet), Gerd Lärfars, Lars Sandman (0000-0003-0987-7653, Linköping University), Niklas Juth (0000-0002-1339-4956, Karolinska Institutet) |
| Year | 2022 |
| Volume | 48 |
| Issue | 3 |
| Pages | 193-193 |
| Publication date | 2022-03-01 |
| Open Access | No |
| Type | ARTICLE |
| Venue | Journal of Medical Ethics (JOURNAL) |
| Journal identifiers | ISSN: 0306-6800 • E-ISSN: 1473-4257 |
| Publisher | BMJ (PUBLISHER • GB) |
| DOI | 10.1136/medethics-2022-108157 |
| PMID | 35115409 |
| OpenAlex | W4210554253 |
| Language | EN |
| References cited | 3 |
Alzheimer's disease · Data science · Disease · Pathology · Computer Science · Health Systems, Economic Evaluations, Quality of Life · Medicine · Mental Health and Psychiatry · Neuroethics, Human Enhancement, Biomedical Innovations
| Highly cited | No |
|---|